Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380291218> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4380291218 abstract "The efficacy of definite for non-small-cell lung cancer (NSCLC) with uncommon epidermal growth factor receptor (EGFR) mutations has been preliminarily demonstrated. However, there is a paucity of data with which to compare the efficacy and safety of second- and third-generation TKIs in patients with NSCLC carrying uncommon EGFR mutations.We compared the efficacy and safety of second- and third-generation TKIs in all NSCLC patients in whom next-generation sequencing confirmed uncommon EGFR mutations, including G719X, S768I, and L861Q. The parameters analyzed included the objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), and overall survival (OS). The rate of treatment-related adverse events (AEs) reflected the safety of these TKIs.Eighty-four NSCLC patients with uncommon EGFR mutations were enrolled between April 2016 and May 2022 at Zhejiang Cancer Hospital, including 63 treated with second-generation TKIs and 21 treated with third-generation TKIs. The ORR for all patients receiving TKIs was 47.6%, and the DCR was 86.9%. The median PFS for NSCLC patients with uncommon EGFR mutations receiving TKIs was 11.9 months and OS was 30.6 months. There was no significant difference in PFS after treatment with second- or third-generation TKIs (13.3 vs. 11.0 months, respectively, P = 0.910) or in OS (30.6 vs. 24.6 months, respectively P = 0.623). The third-generation TKIs showed no severe toxicity.The efficacy of second- and third-generation TKIs for NSCLC with uncommon EGFR mutations does not differ, and so can be used to treat NSCLC patients with these mutations." @default.
- W4380291218 created "2023-06-13" @default.
- W4380291218 creator A5007646657 @default.
- W4380291218 creator A5042187541 @default.
- W4380291218 creator A5059841754 @default.
- W4380291218 creator A5066879163 @default.
- W4380291218 creator A5067987141 @default.
- W4380291218 creator A5089652548 @default.
- W4380291218 date "2023-06-12" @default.
- W4380291218 modified "2023-10-03" @default.
- W4380291218 title "Comparison of efficacy and safety of second‐ and third‐generation <scp>TKIs</scp> for non‐small‐cell lung cancer with uncommon <scp>EGFR</scp> mutations" @default.
- W4380291218 cites W1975276584 @default.
- W4380291218 cites W2053603900 @default.
- W4380291218 cites W2111662961 @default.
- W4380291218 cites W2139804581 @default.
- W4380291218 cites W2149733252 @default.
- W4380291218 cites W2154130790 @default.
- W4380291218 cites W2171139285 @default.
- W4380291218 cites W2251851976 @default.
- W4380291218 cites W2296139876 @default.
- W4380291218 cites W2398778057 @default.
- W4380291218 cites W2560717039 @default.
- W4380291218 cites W2914348809 @default.
- W4380291218 cites W2985811291 @default.
- W4380291218 cites W2995864319 @default.
- W4380291218 cites W3000009976 @default.
- W4380291218 cites W3011521712 @default.
- W4380291218 cites W3012479383 @default.
- W4380291218 cites W3030703193 @default.
- W4380291218 cites W3087614196 @default.
- W4380291218 cites W4212913392 @default.
- W4380291218 cites W4312170659 @default.
- W4380291218 cites W4315866328 @default.
- W4380291218 cites W4320475217 @default.
- W4380291218 cites W4380291218 @default.
- W4380291218 doi "https://doi.org/10.1002/cam4.6229" @default.
- W4380291218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37306192" @default.
- W4380291218 hasPublicationYear "2023" @default.
- W4380291218 type Work @default.
- W4380291218 citedByCount "2" @default.
- W4380291218 countsByYear W43802912182023 @default.
- W4380291218 crossrefType "journal-article" @default.
- W4380291218 hasAuthorship W4380291218A5007646657 @default.
- W4380291218 hasAuthorship W4380291218A5042187541 @default.
- W4380291218 hasAuthorship W4380291218A5059841754 @default.
- W4380291218 hasAuthorship W4380291218A5066879163 @default.
- W4380291218 hasAuthorship W4380291218A5067987141 @default.
- W4380291218 hasAuthorship W4380291218A5089652548 @default.
- W4380291218 hasBestOaLocation W43802912181 @default.
- W4380291218 hasConcept C121608353 @default.
- W4380291218 hasConcept C126322002 @default.
- W4380291218 hasConcept C143998085 @default.
- W4380291218 hasConcept C197934379 @default.
- W4380291218 hasConcept C2776256026 @default.
- W4380291218 hasConcept C2779438470 @default.
- W4380291218 hasConcept C3018907156 @default.
- W4380291218 hasConcept C41008148 @default.
- W4380291218 hasConcept C71924100 @default.
- W4380291218 hasConcept C76155785 @default.
- W4380291218 hasConceptScore W4380291218C121608353 @default.
- W4380291218 hasConceptScore W4380291218C126322002 @default.
- W4380291218 hasConceptScore W4380291218C143998085 @default.
- W4380291218 hasConceptScore W4380291218C197934379 @default.
- W4380291218 hasConceptScore W4380291218C2776256026 @default.
- W4380291218 hasConceptScore W4380291218C2779438470 @default.
- W4380291218 hasConceptScore W4380291218C3018907156 @default.
- W4380291218 hasConceptScore W4380291218C41008148 @default.
- W4380291218 hasConceptScore W4380291218C71924100 @default.
- W4380291218 hasConceptScore W4380291218C76155785 @default.
- W4380291218 hasLocation W43802912181 @default.
- W4380291218 hasLocation W43802912182 @default.
- W4380291218 hasOpenAccess W4380291218 @default.
- W4380291218 hasPrimaryLocation W43802912181 @default.
- W4380291218 hasRelatedWork W1967103478 @default.
- W4380291218 hasRelatedWork W2032912323 @default.
- W4380291218 hasRelatedWork W2054822224 @default.
- W4380291218 hasRelatedWork W2186047679 @default.
- W4380291218 hasRelatedWork W2356834128 @default.
- W4380291218 hasRelatedWork W2372561159 @default.
- W4380291218 hasRelatedWork W2375344515 @default.
- W4380291218 hasRelatedWork W2390152934 @default.
- W4380291218 hasRelatedWork W2542192317 @default.
- W4380291218 hasRelatedWork W2597201175 @default.
- W4380291218 isParatext "false" @default.
- W4380291218 isRetracted "false" @default.
- W4380291218 workType "article" @default.